Alles Mark J
- SEC CIK
- 0001538897
No open-market purchases or sales filed in the past year.
Current role at each company
- SYRS Syros Pharmaceuticals, Inc.Directoras of Sep 19, 2023
- BMRN Biomarin Pharmaceutical IncDirectoras of May 24, 2023
- TPTX Turning Point Therapeutics, Inc.Directoras of Aug 17, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Alles Mark J as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BMRN Biomarin Pharmaceutical Inc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 2, 2022 (view filing) | Oct 31 | 2 days | Alles Mark JDirector | PPurchase | +3.63K | $86.75 | +$314.5K | +49.8%10.9K after |